Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events

Clinical trial NCT01110291 · COMPLETED

Trial details

NCT number: NCT01110291
Sponsor: University of Turku
Status: COMPLETED
Study type: OBSERVATIONAL

CYP3A Phenotyping CYP3A5 and MDR1 Genotyping Docetaxel Toxicity Associations Between Genetic Data and Docetaxel Toxicity

Start date: 2003-04-01
Primary completion: 2004-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.